About the Webinar:
In the November of 2020, the OIG issued a Special Fraud Alert for speaker programs in the life sciences industry. Following this alert, the PhRMA Code was also revised in August 2021 to help the industry prepare well and adhere to the regulations around speaker programs.
Continuing our streak of bringing the most updated and valuable content for our compliance community, we’re tying up with Sharon R. Delshad, Principal at Rebel Compliance to share recommended uses of data for planning and conducting monitoring and auditing of Speaker Programs based on the 2020 OIG Special Fraud Alert on Speaker Programs, recent Corporate Integrity Agreements, and updates to the 2021 PhRMA Code on Interactions with Healthcare Provider.
Key Takeaways:
- The Speaker Program risks emphasized by the OIG
- Speaker Program-specific Compliance requirements updates
- Why tracking data is important for Sales, Marketing, and Compliance
- How to use data for targeting risk-based Programs for live monitoring
- Automated audits of Speaker Program data
Who Should Attend:
Mid-level to Senior Compliance professionals at drug or medical device manufacturing companies, legal consultants working in the life sciences compliance industry.
